Outsourcing

Chemocatalysis and biocatalysis are important elements of an effective strategy for improving yield and stereoselectivty.

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?

A Pharma Business Imperative.

Agreement on standards for excipient qualification, development, and fair pricing is underway.

A modular approach to biopharmaceutical production could bring process flexibility, and contract manufacturing organizations are beginning to take notice.

When vessels, seals, and cooling units go haywire, operators must get in the mix.

The author describes the new IPEA excipient good-manufacturing-practice certification program that is now ANSI accredited. This article is part of a special issue on excipients and solid dosage.

Charles River Acquires WuXi AppTec; Amgen Appoints President and COO; and More.

The Society of Chemical Manufacturers and Affiliates is raising concerns over a recently introduced bill in the US Senate, which seeks to reform the Toxic Substances Control Act.

INTERPHEX 2010 will take place this week at the Jacob K. Javits Center in New York.

FDA Issues Warning Letters to Astellas, GSK, And Novartis; Sandoz Acquires Oriel Therapeutics; And More.

Cephalon Completes Acquisition of Mepha; Xcellerex Appoints President and CEO; and More.

Eli Lily Wins Court Battle; Genzyme Appoints COO; And More.

Collaboration has been key to the pharmacopeia's achievement.

As drug manufacturing and standards grow, pharmacopeias must adapt to meet new challenges.

As the industry continues to evolve, do we know where we're headed?

An established show has several new programs that reflect the industry's current challenges.

Laboratory personnel share interesting tales as well as stories of unexpected tails.

As demand for global vaccine development and production grows, all eyes are turning to Asia.

Interphex Showcase 2010.

The BIO convention, and healthcare reform, could re-energize biotech.

Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.

Growth in the market for monoclonal antibodies, recombinant proteins, and vaccines creates new opportunities for drug companies and suppliers.

Pfizer Invests In Nodality; SOCMA Approves New Members; And More.

Seventeen pharmaceutical markets are now ranked as "pharmerging," according to market-research firm IMS Health.